Collection / TB-500
TB-500
TB-500 is a short thymosin-related peptide fragment of interest in tissue-repair literature and peptide identification. Its exact sequence is central to separating fragment research from full-length thymosin beta-4.
Simulation only · No real order or payment.
Synthetic peptide related to thymosin beta-4
Also known as: TB500
Analytical identityResearch & handling
Not for human or veterinary use. Storage, handling, identity and purity require verified batch documentation. No dosing or treatment advice is provided.
At a glance
Fragment identity
Analytical studies identified Ac-LKKTETQ in the tested material.
Peptide analysis
Chromatography and mass spectrometry help distinguish the fragment and its metabolites.
Tissue-research context
Full-length thymosin beta-4 is a different molecule; its wound-model findings are kept separate.
Explore the study context and sources below. For laboratory research only.
Studies & context
Studied analytically to identify the short thymosin-related fragment; molecular identity matters before comparing wound-model literature.
Analytical identityChromatography and mass spectrometry identified Ac-LKKTETQ in the TB-500 product examined in 2012.
Study limitations
This identifies that study sample, not PEPTIVIA’s material or every TB-500 listing.
A separate study detected the fragment and its metabolites in equine samples.
Study limitations
An analytical detection study, not evidence of human efficacy; full-length thymosin beta-4 findings cannot be substituted.
Published research is separate from PEPTIVIA identity, content, purity, sterility and batch documentation. No source-supplier report verifies PEPTIVIA material.